Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Promex Medical is a medical device company headquartered in Brazil that specializes in the design and manufacture of specialized needles and instruments for biopsy and infusion. Established in 1993, the company is a prominent player in the oncology and hematology markets, offering a range of products including bone marrow aspiration needles (Mielocan), bone marrow biopsy needles (Mielostar), and soft tissue biopsy systems (Histocan). While its US-based product line was acquired by Argon Medical Devices in 2018, Promex Medical continues to operate as an independent manufacturer and distributor, serving healthcare providers across Latin America and international markets. The company is recognized for its commitment to quality, maintaining ISO 13485 certification and CE marking for its surgical instruments. Its products are widely used in diagnostic procedures for various cancers and hematological disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Promex Medical.